Nearly Pain-Free Self-administration of Subcutaneous Methotrexate With an Autoinjector: Results of a Phase 2 Clinical Trial in Patients With Rheumatoid Arthritis Who Have Functiona...

por Freundlich, Bruce, Kivitz, Alan, Jaffe, Jonathan S.
Publicado 2014

Safe and Effective Subcutaneous Self-Injection of Bimekizumab with Safety Syringe and Auto-Injector Devices: Results from a Multicenter, Randomized, Open-Label Study in Patients wi...

por Kivitz, Alan, Ellis, Alicia M, Shende, Vishvesh, Lambert, Jérémy, Tatla, Daljit
Publicado 2023

Assessing usability, label comprehension, pen robustness and pharmacokinetics of a self-administered prefilled autoinjector pen of methotrexate in patients with rheumatoid arthriti...

por Pachon, Jaime A, Kivitz, Alan J, Heuer, Kay-Uwe, Pichlmeier, Uwe
Publicado 2014

A randomized, phase IIa study to assess the systemic exposure of triamcinolone acetonide following injection of extended-release triamcinolone acetonide or traditional triamcinolon...

por Kivitz, Alan, Kwong, Louis, Shlotzhauer, Tammi, Lufkin, Joelle, Cinar, Amy, Kelley, Scott
Publicado 2019

Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA)

por Bingham, Clifton O, Rizzo, Warren, Kivitz, Alan, Hassanali, Azra, Upmanyu, Ruchi, Klearman, Micki
Publicado 2015

Rescue Analgesic Medication Use by Patients Treated with Triamcinolone Acetonide Extended-Release for Knee Osteoarthritis Pain: Pooled Analysis of Three Phase 2/3 Randomized Clinic...

por Kivitz, Alan J., Conaghan, Philip G., Cinar, Amy, Lufkin, Joelle, Kelley, Scott D.
Publicado 2019

Long-Term Safety and Efficacy of Subcutaneously Administered Tocilizumab for Adult Rheumatoid Arthritis: A Multicenter Phase 3b Long-term Extension Study

por Kivitz, Alan, Wallace, Thomas, Olech, Ewa, Borofsky, Michael, Devenport, Jenny, Pei, Jinglan, Michalska, Margaret
Publicado 2016

Simulating clinical trial visits yields patient insights into study design and recruitment

por Lim, S Sam, Kivitz, Alan J, McKinnell, Doug, Pierson, M Edward, O’Brien, Faye S
Publicado 2017

Tolerogenic nanoparticles mitigate the formation of anti-drug antibodies against pegylated uricase in patients with hyperuricemia

por Sands, Earl, Kivitz, Alan, DeHaan, Wesley, Leung, Sheldon S., Johnston, Lloyd, Kishimoto, Takashi Kei
Publicado 2022

A Randomized, Open-Label, Single-Dose Study to Assess Safety and Systemic Exposure of Triamcinolone Acetonide Extended-Release in Patients With Hip Osteoarthritis

por Kivitz, Alan, Mehra, Purvi, Hanson, Peter, Kwong, Louis, Cinar, Amy, Lufkin, Joelle, Kelley, Scott
Publicado 2022

Safety and Systemic Exposure of Triamcinolone Acetonide Following Ultrasound-Guided Intra-Articular Injection of Triamcinolone Extended-Release or Standard Triamcinolone Acetonide...

por Hanson, Peter, Kivitz, Alan, Mehra, Purvi, Kwong, Louis, Cinar, Amy, Lufkin, Joelle, Kelley, Scott D.
Publicado 2021

The MIDORA trial: a phase II, randomised, double-blind, placebo-controlled, mechanistic insight and dosage optimisation study of the efficacy and safety of dazodalibep in patients...

por Kivitz, Alan, Wang, Liangwei, Alevizos, Ilias, Gunsior, Michele, Falloon, Judith, Illei, Gabor, St Clair, E William
Publicado 2023

Double-Blind Randomized Trials of Single-Tablet Ibuprofen/High-Dose Famotidine vs. Ibuprofen Alone for Reduction of Gastric and Duodenal Ulcers

por Laine, Loren, Kivitz, Alan J, Bello, Alfonso E, Grahn, Amy Y, Schiff, Michael H, Taha, Ali S
Publicado 2012

Disease–Drug Interaction of Sarilumab and Simvastatin in Patients with Rheumatoid Arthritis

por Lee, Eun Bong, Daskalakis, Nikki, Xu, Christine, Paccaly, Anne, Miller, Barry, Fleischmann, Roy, Bodrug, Inga, Kivitz, Alan
Publicado 2016

Efficacy and safety of tofacitinib by background methotrexate dose in psoriatic arthritis: post hoc exploratory analysis from two phase III trials

por Kivitz, Alan J., FitzGerald, Oliver, Nash, Peter, Pang, Shirley, Azevedo, Valderilio F., Wang, Cunshan, Takiya, Liza
Publicado 2021

Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized contro...

por Bickham, Kara, Kivitz, Alan J., Mehta, Anish, Frontera, Nancy, Shah, Sandhya, Stryszak, Paul, Popmihajlov, Zoran, Peloso, Paul M.
Publicado 2016

Single-Arm Study of Etanercept in Adult Patients with Moderate to Severe Rheumatoid Arthritis Who Failed Adalimumab Treatment

por Bessette, Louis, Khraishi, Majed, Kivitz, Alan J., Kaliyaperumal, Arunan, Grantab, Rama, Poulin-Costello, Melanie, Isaila, Maya, Collier, David
Publicado 2017

Secukinumab provides sustained improvements in the signs and symptoms of active ankylosing spondylitis with high retention rate: 3-year results from the phase III trial, MEASURE 2

por Marzo-Ortega, Helena, Sieper, Joachim, Kivitz, Alan, Blanco, Ricardo, Cohen, Martin, Delicha, Evie-Maria, Rohrer, Susanne, Richards, Hanno
Publicado 2017

Efficacy and Safety of Secukinumab 150 mg with and Without Loading Regimen in Ankylosing Spondylitis: 104-week Results from MEASURE 4 Study

por Kivitz, Alan J., Wagner, Ulf, Dokoupilova, Eva, Supronik, Jerzy, Martin, Ruvie, Talloczy, Zsolt, Richards, Hanno B., Porter, Brian
Publicado 2018

An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis

por Cohen, Stanley, Pablos, Jose L., Pavelka, Karel, Müller, Gerard Anton, Matsumoto, Alan, Kivitz, Alan, Wang, Hui, Krishnan, Eswar
Publicado 2019